• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

保留肾单位手术治疗伴有肿瘤栓子的肾细胞癌。

Nephron-Sparing Surgery for Renal Cell Carcinoma with Tumor Thrombus.

机构信息

Department of Surgery, University of Miami Miller School of Medicine, Jackson Memorial Hospital, Miami, Florida, USA.

Department of Urology, University of Miami Miller School of Medicine, Jackson Memorial Hospital, Miami, Florida, USA.

出版信息

Urol Int. 2022;106(4):419-425. doi: 10.1159/000516697. Epub 2021 Jun 28.

DOI:10.1159/000516697
PMID:34182558
Abstract

OBJECTIVE

The aim of the study was to describe our experience in patients who underwent nephron-sparing surgery (NSS) with tumor thrombectomy.

PATIENTS AND METHODS

Three consecutive patients who underwent NSS and tumor thrombectomy for localized single/multifocal renal cell carcinomas (RCCs) in conjunction with tumor thrombus between 2007 and 2011 were included. Open partial nephrectomy and thrombectomy was performed. Reconstruction included main renal vein, collecting system, and remaining parenchymal closure. One of the cases required additional artery repair and flushing with preservation solution.

RESULTS

Ischemic time was kept for 30-40 min. Mean estimated blood loss was 183.3 cc (range:100-300). One patient required the transfusion of 1 packed red blood cells unit. One of the patients developed a urinary fistula requiring double-J stenting. Hospital staying ranged between 5 and 8 days. None of the patients required renal replacement therapy either postoperatively or in the follow-up. Serum creatinine level at last follow-up (mean 83 months) ranged from 0.8 to 2.8 mg/dL.

CONCLUSION

Our experience supports the feasibility of imperative partial nephrectomy and tumor thrombectomy for cases of RCC with renal vein involvement by tumor thrombus. In experienced hands, this approach may offer the patient a low morbidity postoperative course and long-term freedom from disease while maintaining the renal function, thus avoiding the need of renal replacement therapy.

摘要

目的

本研究旨在描述我们在接受肾部分切除术(NSS)联合肿瘤栓子切除术的患者中的经验。

患者和方法

纳入 2007 年至 2011 年间连续 3 例接受 NSS 和肿瘤栓子切除术治疗局限性单发/多发肾细胞癌(RCC)合并肿瘤栓子的患者。采用开放部分肾切除术和栓子切除术。重建包括主肾静脉、收集系统和剩余实质的闭合。其中 1 例需要额外的动脉修复和用保存液冲洗。

结果

缺血时间保持在 30-40 分钟。平均估计失血量为 183.3cc(范围:100-300)。1 例患者需要输注 1 个单位的浓缩红细胞。1 例患者发生尿瘘,需要双 J 支架置入。住院时间为 5-8 天。术后或随访期间均无需行肾脏替代治疗。末次随访时(平均 83 个月)血清肌酐水平为 0.8-2.8mg/dL。

结论

我们的经验支持在经验丰富的医生手中,对合并肾静脉受累肿瘤栓子的 RCC 患者进行强制性部分肾切除术和肿瘤栓子切除术的可行性。这种方法可能为患者提供低术后发病率和长期无病生存率,同时保持肾功能,从而避免需要肾脏替代治疗。

相似文献

1
Nephron-Sparing Surgery for Renal Cell Carcinoma with Tumor Thrombus.保留肾单位手术治疗伴有肿瘤栓子的肾细胞癌。
Urol Int. 2022;106(4):419-425. doi: 10.1159/000516697. Epub 2021 Jun 28.
2
Partial nephrectomy in two patients with known T3a tumours involving the renal vein.两名 T3a 期肿瘤累及肾静脉的患者行部分肾切除术。
BJU Int. 2012 May;109(9):1345-8. doi: 10.1111/j.1464-410X.2011.10477.x. Epub 2011 Aug 24.
3
Kidney autotransplantation after nephrectomy and work bench surgery as an ultimate approach to nephron-sparing surgery.肾切除术后肾自体移植和工作檯手术作为保肾手术的终极方法。
World J Surg Oncol. 2018 Feb 20;16(1):35. doi: 10.1186/s12957-018-1338-1.
4
NEPHRON-SPARING SURGERY IN PATIENTS WITH RENAL CELL CARCINOMA EXTENDING TO THE MAIN RENAL VEIN: INTRARENAL AND EXTRARENAL THROMBECTOMY.肾细胞癌侵犯主肾静脉患者的保肾手术:肾内及肾外血栓切除术
Georgian Med News. 2019 Dec(297):23-30.
5
Robotic Radical Nephrectomy and Thrombectomy for Left Renal Cell Carcinoma with Renal Vein Tumor Thrombus: Superior Mesenteric Artery as an Important Strategic Dividing Landmark.机器人根治性肾切除术和血栓切除术治疗左肾细胞癌合并肾静脉癌栓:肠系膜上动脉作为重要的战略分界标志。
J Endourol. 2019 Jul;33(7):557-563. doi: 10.1089/end.2019.0159. Epub 2019 Jun 18.
6
Management of small unilateral renal cell carcinomas: radical versus nephron-sparing surgery.小的单侧肾细胞癌的治疗:根治性手术与保留肾单位手术对比
Urology. 1995 Jan;45(1):34-40; discussion 40-1. doi: 10.1016/s0090-4295(95)96306-5.
7
Nephron-sparing surgery for renal cell carcinoma in the solitary kidney.对孤立肾肾细胞癌行保留肾单位手术。
Scand J Urol Nephrol. 2007;41(1):10-3. doi: 10.1080/00365590600911225.
8
Single institutional experience with nephron-sparing surgery for pathologic stage T3bNxM0 renal cell carcinoma confined to the renal vein.单中心经验:保留肾单位手术治疗局限于肾静脉的病理分期 T3bNxM0 肾细胞癌。
Urology. 2010 Sep;76(3):639-42. doi: 10.1016/j.urology.2009.10.073. Epub 2010 Feb 16.
9
Oncologic outcomes of nephron-sparing surgery in patients with T1 multifocal renal cell carcinoma.T1 多灶性肾细胞癌患者行保留肾单位手术的肿瘤学结局。
Clin Transl Oncol. 2019 Jun;21(6):760-765. doi: 10.1007/s12094-018-1984-3. Epub 2018 Nov 15.
10
Preservation surgery in patients with localized renal cell cancer--nephron sparing surgery.局限性肾细胞癌患者的保留肾单位手术——保留肾单位手术。
Acta Chir Iugosl. 2014;61(1):45-9.

引用本文的文献

1
Optimizing outcomes of partial nephrectomy in patients with tumors in solitary kidneys: a non-systematic review.优化孤立肾肿瘤患者肾部分切除术的治疗效果:一项非系统性综述
J Med Life. 2025 Apr;18(4):270-276. doi: 10.25122/jml-2025-0066.
2
A refined kidney tumor nephrometry system employed to screen pediatric patients who are eligible for nephron sparing surgery.一种用于筛查适合保留肾单位手术的儿科患者的精密肾肿瘤测量系统。
Front Pediatr. 2025 Jan 7;12:1501560. doi: 10.3389/fped.2024.1501560. eCollection 2024.